Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T
27. Oktober 2021 02:15 ET
|
Curium
St. Louis, MO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Curium announced today that the Company has received a Study May Proceed letter from the U.S. Food and Drug Administration (FDA) to begin its Phase 3...
Curium to Expand Noblesville Facility’s Workforce
28. April 2021 02:30 ET
|
Curium
St. Louis, MO, April 28, 2021 (GLOBE NEWSWIRE) -- Curium, the world’s largest nuclear medicine company, has announced plans to invest in new jobs at its Noblesville location – furthering its...
RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)
26. Januar 2021 02:30 ET
|
Curium
St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a...